medication-access
(2)
Dan Cornwell
Dan Cornwell is the founder and CEO of PrescriberPoint, a Boston-based, AI-enabled medication access platform that helps clinicians cut through the paperwork between writing a prescription and a patient actually getting their medicine. Spun out of Eli Lilly in partnership with BCG Digital Ventures, the company raised seed backing from an unusual coalition of would-be rivals - Lilly, Pfizer, Adobe and Mastercard. Before PrescriberPoint, Cornwell ran the nurse-staffing marketplace IntelyCare and advised companies on building disruptive businesses at BCG Digital Ventures. A Yale historian turned Wharton-trained operator, he keeps returning to the same problem: the messy gap between a good intention and a completed transaction.
Geoffrey Chaiken
Geoffrey Chaiken is the co-founder and CEO of BlinkRx (Blink Health), a New York-based digital health company rebuilding how prescription drugs get priced, paid for, and delivered. The son and grandson of physicians, he gave up a career in medicine to attack what he calls the real bottleneck in healthcare - not discovering new cures, but getting existing ones into patients' hands at a fair price. With his younger brother Matthew, he has raised more than half a billion dollars to digitize both the patient front end and the pharmaceutical industry's back end, partnering with drug makers and tens of thousands of pharmacies to strip middlemen out of the medication supply chain.